Results 21 to 30 of about 120,343 (298)

Outcome of Laparoscopic Splenectomy for Malignant Hematologic Diseases

, 2004
Aim The role of laparoscopic splenectomy in the treatment of hematological diseases is still controversial. The aim of this study was to assess whether the benign or malignant nature of hematological diseases may influence the outcome of laparoscopic ...
Edoardo Rossi, Marco Casaccia, Davide Cavaliere, Paolo Torelli, Gregorio Santori, Umberto Valente, Fabrizio Panaro, Andrea Bacigalupo, Davide Ghinolfi   +8 more
core   +3 more sources

BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES [PDF]

, 2015
Splenectomy, while often necessary in otherwise healthy patients after major trauma, find its primary indication for patients with an underlying malignant or nonmalignant hematologic diseases.
Eligio Pizzigallo, Giuseppe Leone
core   +1 more source

Roles of the intestinal microbiota and microbial metabolites in acute GVHD

Experimental Hematology & Oncology, 2021
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is one of the most curative strategies for the treatment of many hematologic malignancies and diseases. However, acute graft-versus-host disease (GVHD) limits the success of allo-HSCT.
Dandan Lin, Bo Hu, Pengfei Li, Ye Zhao, Yang Xu, Depei Wu   +5 more
doaj   +1 more source

Hematologic disorders in rheumatic diseases

, 1994
Hematologic diseases often have musculoskeletal manifestations, and their diagnosis and treatment are relevant to the rheumatologist. Primary disorders of the blood such as hemophilia or sickle-cell disease may affect bones, joints, or soft tissues ...
Tozman, Elaine
core   +1 more source

Hematologic Manifestations of Helicobacter Pylori Infection [PDF]

, 2023
Helicobacter pylori dünya çapında görülen bir bakteriyel enfeksiyona yol açar. Helicobacter pylori asemptomatik enfeksiyondan, peptik ülser, gastrit, gastrointestinal maligniteye kadar birçok hastalığa yol açar.
Alkan, Sevil, Öztürk, Tuba Erürker, Özlü, Can   +2 more
core   +1 more source

CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL

Biomarker Research, 2023
It was previously believed that patients with Ph-like ALL had poorer prognosis compared with other B-ALL subgroups due to resistance to conventional chemotherapy and lack of targeted drugs.
Hai-ping Dai, Dan-qing Kong, Hong-jie Shen, Wei Cui, Qian Wang, Zheng Li, Jia Yin, Li-qing Kang, Lei Yu, De-pei Wu, Xiao-wen Tang   +10 more
doaj   +1 more source

Patient‐reported physical well‐being predicts good long‐term survival of hematopoietic stem cell transplantation

Cancer Medicine
Aim This study aimed to explore the association between patient‐reported items at different time points after hematopoietic stem cell transplantation (HSCT) and long‐term survival. Methods We conducted a study with 144 allogeneic HSCT patients, following
Yin Lu, Tao You, Qin Ma, Weijuan Wang, Jiaqian Qi, Pan Yang, Yaya Song, Jia Chen, Jianhong Fu, Yongqin Ge, Xiaming Zhu, Depei Wu   +11 more
doaj   +1 more source

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Journal of Hematology & Oncology, 2021
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for acute myeloid leukemia (AML). However, most patients experience relapse after allo-HSCT, with a poor prognosis, and treatment options are limited.
Qingya Cui, Chongsheng Qian, Nan Xu, Liqing Kang, Haiping Dai, Wei Cui, Baoquan Song, Jia Yin, Zheng Li, Xiaming Zhu, Changju Qu, Tianhui Liu, Wenhong Shen, Mingqing Zhu, Lei Yu, Depei Wu, Xiaowen Tang   +16 more
doaj   +1 more source

Serological Responses and Predictive Factors of Booster COVID-19 Vaccines in Patients with Hematologic Malignancies

, 2023
Patients with hematologic malignancies are reported to have a more severe course of coronavirus disease 2019 (COVID-19) and be less responsive to vaccination.
Tzu-Yin Chen, Chien-Tzu Huang, Hui-Hua Hsiao, Shih-Feng Cho, Ming-Lung Yu, Jeng-Shiun Du, Sheng-Fan Wang, Ching-Ping Lee, Yi-Chang Liu, Chung-Feng Huang   +9 more
core   +1 more source

Carcinomas and Carcinoid Tumors of the Lungs and Bronchi in Children and Adolescents: The EXPeRT Recommendations

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Primary lung carcinomas and bronchial carcinoid tumors (BC) are very rare malignancies in childhood. While typical BC and mucoepidermoid carcinomas are mostly low‐grade, localized tumors with a more favorable prognosis than in adults, necessitating avoidance of overtreatment, adenocarcinomas of the lung are often diagnosed at advanced disease ...
Michael Abele, Calogero Virgone, Michaela Kuhlen, Sabine Irtan, Yves Reguerre, Malgorzata Krawczyk, Ewa Bien, Tal Ben‐Ami, Maja Cesen, Ricardo Lopez‐Almaraz, Andrea Ferrari, Gianni Bisogno, Dominik T. Schneider, Abbas Agaimy, Constantin Lapa, Hubert Ducou le Pointe, Rainer Claus, Catherine Daniel, Ines B. Brecht, Daniel Orbach   +19 more
wiley   +1 more source